SEC Form 4 · accession 0001127602-19-009108

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 27, 2019

Accepted (ET)

Mar 1, 2019 · 11:21 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2019	S	200	$141.89	D	282,825	D
Common Stock	Feb 27, 2019	S	4	$141.90	D	282,821	D
Common Stock	Feb 27, 2019	S	103	$141.91	D	282,718	D
Common Stock	Feb 27, 2019	S	30	$141.915	D	282,688	D
Common Stock	Feb 27, 2019	S	300	$141.92	D	282,388	D
Common Stock	Feb 27, 2019	S	100	$141.94	D	282,288	D
Common Stock	Feb 27, 2019	S	100	$141.95	D	282,188	D
Common Stock	Feb 27, 2019	S	400	$141.96	D	281,788	D
Common Stock	Feb 27, 2019	S	230	$142.01	D	281,558	D
Common Stock	Feb 27, 2019	S	133	$142.03	D	281,425	D
Common Stock	Feb 27, 2019	S	100	$142.04	D	281,325	D
Common Stock	Feb 27, 2019	S	100	$142.08	D	281,225	D
Common Stock	Feb 27, 2019	S	90	$142.085	D	281,135	D
Common Stock	Feb 27, 2019	S	110	$142.10	D	281,025	D
Common Stock	Feb 27, 2019	S	300	$142.13	D	280,725	D
Common Stock	Feb 27, 2019	S	200	$142.15	D	280,525	D
Common Stock	Feb 27, 2019	S	100	$142.16	D	280,425	D
Common Stock	Feb 27, 2019	S	200	$142.17	D	280,225	D
Common Stock	Feb 27, 2019	S	200	$142.21	D	280,025	D
Common Stock	Feb 27, 2019	S	100	$142.22	D	279,925	D
Common Stock	Feb 27, 2019	S	38	$142.29	D	279,887	D
Common Stock	Feb 27, 2019	S	100	$142.35	D	279,787	D
Common Stock	Feb 27, 2019	S	74	$142.42	D	279,713	D

No Table II lines on this filing.